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Objective: to evaluate the prevalence of nasal colonization with Staphylococcus aureus in 
individuals with HIV/AIDS under inpatient treatment in a teaching hospital in the state of São 
Paulo (Brazil). Method: a cross-sectional study undertaken in two units specialized in attending 
people living with HIV/AIDS, in the period August 2011 – July 2012. Socio-demographic and 
clinical data was collected through individual interviews and from the medical records; samples 
of nasal secretion were collected with Stuart swabs on the first day of inpatient treatment. 
Ethical aspects were respected. Result: of the 229 individuals with HIV/AIDS hospitalized in this 
period, 169 participated in the study, with Staphylococcus aureus being identified in the culture 
tests of 46 (27.2%) of the individuals, resistance to oxacillin being evidenced in 10 (21.8%) 
participants. Conclusion: the results of the research indicate that the prevalence of colonization 
with Staphylococcus aureus in individuals with HIV/AIDS in the specialized units was considered 
relevant, possibly contributing to future investigations and, moreover, to the implementation of 
measures to prevent and control this pathogen in this population.
Descriptors: Staphylococcus aureus; Methicillin-Resistant Staphylococcus aureus; Acquired 
Immunodeficiency Syndrome; Nursing; Clinical Nursing Research.
Nasal colonization with Staphylococcus aureus in individuals with HIV/
AIDS attended in a Brazilian Teaching Hospital1
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Introduction
Staphylococcus aureus is a gram-positive bacteria 
which colonizes the skin and has a preference for the 
anterior nares, with this colonization’s prevalence 
varying, depending on the population studied. It has a 
mean of 37.2% in the general population, and a rate of 
up to 35.5% in the nasal sites of patients with Human 
Immunodeficiency Virus (HIV)(1-2).
Staphylococcus aureus’s resistance to methicillin 
(MRSA) was first described in Europe in 1961, as a 
nosocomial pathogenic agent(3).
For researching Staphylococcus aureus and, 
principally, MRSA, the sites of the greatest interest are 
the nasal mucosa and the skin, due to their characteristic 
of being naturally colonized.
The colonization of individuals with HIV/AIDS by 
pathogenic micro-organisms has been associated with 
higher risk of morbidity and mortality, principally when 
related to Staphylococcus aureus. Researchers found a 
rate of 76.7% of colonization with this bacteria in this 
population, indicating prolonged hospitalization (over 10 
days) as a risk factor for resistance to methicillin(4).
The prevalence of nasal colonization with 
Staphylococcus aureus varies depending on the 
population studied. The recent use of antibiotics and 
inpatient treatment in the last year have been found as 
independent predictors for nasal MRSA colonization in 
HIV-positive patients treated as outpatients(5).
In individuals living with HIV/AIDS, 
immunosuppression and the constant use of 
antimicrobials can viabilize colonization with multi-
resistant bacteria and the occurrence of infections.
This manuscript’s relevance is explained by the fact 
that publications on the issue of Staphylococcus aureus 
in people living with HIV/AIDS were not found in Nursing 
periodicals in Brazil.
Objective
To evaluate the prevalence of nasal colonization 
with Staphylococcus aureus in individuals with HIV/AIDS 
receiving inpatient treatment in a teaching hospital in 
the state of São Paulo (Brazil).
Method
The present study is quantitative and cross-
sectional and was undertaken in two units which are 
specialized in attending individuals with HIV/AIDS in a 
large* teaching hospital in the state of São Paulo. 
This research project was considered and approved 
by the Research Ethics Committee of the Ribeirão Preto 
School of Nursing (Protocol n° 1304/2011 EERP-USP).
The inclusion criteria established were: to be 
aged over 18 years old; to be aware of the diagnosis 
of infection with HIV/AIDS; to be clinically well enough 
to understand the guidance and to take the decision to 
participate or not. Individuals with HIV/AIDS using any 
ventilatory equipment which would make consenting or 
data collection impossible were excluded, as were those 
who were inpatients before the data collection period.
On the first day of inpatient treatment, (the first 
24 hours) the individual was invited to participate and 
received information referent to the study objective 
and the research’s ethical precepts; once the individual 
had understood and accepted to participate, he or she 
signed the Terms of Free and Informed Consent.
Socio-demographic and clinical data was collected 
through individual interviews and by accessing the 
medical records; the biological material was collected 
respecting the recommended bio-security measures, in 
the period August 2011 – July 2012. The nasal secretion 
was obtained using Stuart swabs, these being rubbed 
lightly in the left and right anterior nares.
The material collected was seeded and the isolation 
and the phenotypic identification of Staphylococcus 
aureus were carried out by an automatized method, 
using Vitek® system cards (BioMérieux™). Susceptibility 
to antimicrobials was tested using the AST-P585 card 
(BioMérieux™).
The data was organized in Microsoft Office and 
Mac Excel 2011 spreadsheets and then exported to 
the Statistical Package for the Social Science program, 
version 17.0. The distribution of the frequencies (mean 
and median) and the subsequent descriptive statistics of 
the data were undertaken.
Results
Of the 229 individuals approached in the period, 
169 (73.8%) participated in the research; these were 
individuals with HIV/AIDS receiving inpatient treatment 
during the data collection period, who met the inclusion 
criteria; 57.4% were male, their ages varied between 
19 and 72 years, with a mean of 42 years, and 39.6% 
of them were in the age range between 40 and 49 years 
*In the Brazilian context, a ‘large’ hospital is one with between 150 and 500 beds. Translator’s note.
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old. White ethnicity was predominant, corresponding 
to 63.9% of the participants. In relation to education, 
45.0% of the interviewees had completed primary 
school, and only 3.6% stated that they had completed 
higher education.
The microbial analysis of the material resulted in 
123 (72.8%) non-colonized individuals and 46 who were 
colonized with Staphylococcus aureus in the nostrils, 
which corresponds to a prevalence of 27.2%. Among 
those who were colonized, 36 (78.3%) presented 
Staphylococcus aureus which was sensitive to oxacillin, 
these being denominated MSSA, and 10 (21.7%) were 
resistant to oxacillin, these known as MRSA. 
Nasal colonization with Staphylococcus aureus was 
observed more in male individuals with HIV/AIDS, with 
Table 1 - Distribution of the individuals with HIV/AIDS receiving inpatient treatment in two units of a teaching hospital 
(N=169) by socio-demographic variables and nasal colonization with Staphylococcus aureus, sensitive to (MSSA), 
and resistant to, oxacillin (MRSA). Ribeirão Preto, SP, Brazil, 2011-2012
52.8% MSSA and 90.0% MRSA, the predominant age 
range being 30 to 39 years old, with 36.1% MSSA and 
60.0% MRSA being evidenced in this age range. The level 
of education prevalent among the individuals with HIV/
AIDS who were colonized in the nostrils with MSSA was 
equally distributed in the following categories: primary 
education incomplete and primary education complete, 
each with 36.1%; among those colonized in the nostrils 
with MRSA, there was predominance in the category 
‘primary education complete’, 60% of the participants 
having this phenotype.
Table 1 presents the individuals with HIV/AIDS 
by the variables: sex, age, ethnicity, education, and 
classification regarding colonization or non-colonization 




MSSA (n=36) MRSA (n=10)
f % f % f %
Sex
Male 69 56.1 19 52.8 9 90.0
Female 54 43.9 17 47.2 1 10.0
Age range
19 to 29 11 8.9 6 16.7 1 10.0
30 to 39 32 26.0 13 36.1 6 60.0
40 to 49 54 43.9 12 33.3 1 10.0
50 to 59 20 16.3 2 5.6 1 10.0
≥60 6 4.9 3 8.3 1 10.0
Education
Illiterate 8 6.5 2 5.6 1 10.0
Primary - incomplete 29 23.6 13 36.1 3 30.0
Primary - complete 57 46.3 13 36.1 6 60.0
Secondary - complete 24 19.5 7 19.4 0 0.0
Higher Ed. - complete 5 4.1 1 2.8 0 0.0
In relation to the viral load of the HIV, MSSA was 
isolated in 16 (44.4%) of the individuals with HIV/AIDS 
who had counts below 100 copies/ml, while MRSA was 
identified in 4 (40.0%) of the individuals in the same 
range of viral load count. In relation to the determination 
of CD4+ T lymphocytes, among those colonized with 
MSSA and MRSA, there was a predominance of the range 
below 200 cells/mm³ in 16 (44.4%) and 6 (60.0%) 
individuals, respectively. 
Regarding the number of episodes of inpatient 
treatment in the previous six months, it was observed 
that 44.4% of the individuals with HIV/AIDS colonized 
with MSSA, and 30.0% of the individuals with HIV/
AIDS colonized with MRSA, had not received inpatient 
treatment in the period. Among the participants with 
MRSA, 60.0% mentioned one episode of inpatient 
treatment in the previous six month period. The 
use of antimicrobials was observed in 66.7% of the 
individuals with HIV/AIDS with MSSA, and in 80.0% of 
the individuals with HIV/AIDS with MRSA, evidencing 
the predominance of the use of antimicrobials in those 
colonized with Staphylococcus aureus.
The use of antiretroviral drugs was identified in 
43.5% of the individuals colonized with MSSA, not 
being observed in 60.0% of those individuals colonized 
with MRSA. 
Table 2 brings together the characterization of 
those subjects classified as colonized or not, with MSSA 
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or MRSA, by the variables of viral load, CD4+ T cell 
count, number of episodes of inpatient treatment in the 
Table 2 - Distribution of the individuals with HIV/AIDS receiving inpatient treatment in two units of a teaching hospital 
(N=169) by the variables of the disease, treatment, hospitalization and colonization with Staphylococcus aureus, 
sensitive to oxacillin (MSSA) and resistant to oxacillin (MRSA). Ribeirão Preto, SP, Brazil, 2011-2012





MSSA (n=36) MRSA (n=10)
f % f % f %
Viral load (copies/ml)
≤100 39 31.7 16 44.4 4 40.0
101 to 100,000 45 36.6 12 33.3 2 20.0
100,001 to 500,000 24 19.5 4 11.1 1 10.0
≥500,001 12 9.8 0 0.0 3 30.0
Information unavailable 3 2.4 4 11.1 0 0.0
CD4 T Lymphocytes (cell/mm3)
>350 29 23.6 9 25.0 2 20.0
200 to 350 15 12.2 10 27.8 2 20.0
<200 76 61.8 16 44.4 6 60.0
Information unavailable 3 2.4 1 2.8 0 0.0
Episodes of inpatient treatment
None 45 36.6 16 44.4 3 30.0
One 41 33.3 10 27.8 6 60.0
≥Two 37 30.1 10 27.8 1 10.0
Use of antimicrobials (ATM)
Yes 84 68.3 24 66.7 8 80.0
No 39 31.7 12 33.3 2 20.0
Use of antirretroviral drugs (ARV)
Yes 55 44.7 20 43.5 4 40.0
No 68 55.3 16 34.8 6 60.0
Discussion
Of the samples collected from the nostrils of 169 
(73.8%) individuals with HIV/AIDS receiving inpatient 
treatment in a large teaching hospital, 46 (27.2%) were 
positive for Staphylococcus aureus, of whom 36 (78.3%) 
were identified as MSSA and 10 (21.7%), as MRSA.
The male sex was more frequent in the population 
studied, both in those individuals who were colonized 
and among those who were not. The predominant age 
range was from 30 to 39 years of age among those 
colonized with Staphylococcus aureus. The predominant 
level of schooling was completed primary school.
A similar, retrospective, study, with individuals 
with HIV/AIDS, undertaken to identify risk factors for 
colonization or infection with MRSA, obtained results 
showing that 63.0% of the participants were male and 
that the mean age was 41 years old (22 to 60 years old). 
Nasal colonization in individuals with HIV/AIDS was 
identified more in those who had a low viral load (≤100 
copies/ml), CD4+ T lymphocytes count <200 cells/mm3, 
those with a history of at least one episode of inpatient 
treatment in the previous six months, and who were using 
antimicrobials. Only MRSA was identified with greater 
frequency among the individuals who were not using 
antiretroviral drugs, as, in the MSSA evidence, the majority 
of the participants were using antiretroviral drugs.
Previous research had identified a rate of 34% 
of nasal colonization with Staphylococcus aureus in 
individuals with HIV, emphasizing being a nasal carrier, 
having a vascular catheter, a low CD4+ T lymphocyte 
count and neutropenia as important risk factors for 
infections related to this pathogen(7).
Research conducted among individuals with HIV 
found that 83.3% of the nasal carriers of Staphylococcus 
aureus were patients with CD4 T lymphocytes <200 cells/
mm3, while among those who had a CD4 T cell count 
above 300 cells/mm3, MRSA was not isolated(4).
Inpatient treatment, the previous use of 
antimicrobials, skin/soft tissue infection or being HIV-
positive may all be considered as risk factors for patients 
who presented colonization with MRSA(8). 
Some risk factors for MRSA infection are indicated 
for individuals living with HIV, the following being 
highlighted: the immunosuppressed condition, and 
associated co-morbidities and specified life-style-related 
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behaviors, such as high-risk sexual practices and the 
use of illicit drugs(9).
The use of antimicrobials has also been documented 
as a risk factor for colonization with Staphylococcus 
aureus in individuals with HIV(10).
The use of antiretroviral drugs and the prophylactic 
use of Trimethoprim/sulfamethoxazole (TMP/SMX) are 
included among probable protective factors against 
colonization with Staphylococcus aureus among 
individuals with HIV(6,10-11).
Some measures for the prevention and control 
of MRSA can be instituted, such as the investigation 
of patients who are suspected of being colonized or 
infected with MRSA, as well as this patient’s restriction in 
the hospital environment (private room and bathroom); 
the investigation of body sites with swabs (nasal site, 
the genital region), and the use of personal protective 
equipment for the health professionals when in direct 
contact with the suspected cases, followed by the 
treatment and decolonization of patients and health 
professionals identified as colonized(12).
One study undertaken with health professionals 
emphasizes the need to implement strategies which 
cover public policies directed at programs for the control 
of this pathogen in the hospital setting, promoting broad 
discussions on this topic(13).
Conclusion
The concern with identifying colonization with 
Staphylococcus aureus in the population which lives 
with HIV/AIDS is growing, in view of the need for 
interventions for controlling the spread of this pathogen, 
minimizing correlated future infections.
In spite of being a bacteria first isolated in human 
beings over four decades ago, Staphylococcus aureus 
commonly causes the infection of skin and soft tissues, 
among others, both in people receiving inpatient 
treatment and those living in the community.
It is necessary for there to be joint action from 
professionals and government bodies linked to health, so 
as to improve policies of control related to antimicrobial 
resistance and to multi-drug-resistant micro-organisms.
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